Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2339-2342

  Su, Gloria H ^a   Hilgers, Werner ^a   Shekher, Manu C ^a   Tang, David J ^a   Yeo, Charles J ^a   Hruban, Ralph H ^a   Kern, Scott E ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; BILE DUCT CARCINOMA; BREAST CARCINOMA; GENE FUNCTION; GENE MAPPING; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; PANCREAS CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

BILIARY TRACT NEOPLASMS; BREAST NEOPLASMS; CHROMOSOME MAPPING; EXONS; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED;

EID: 0032100617     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
2. Knudson, A. G., Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
3. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., and Kern, S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025-3033, 1994.
4. Nagase, H., Miyoshi, Y., Horii, A., Aoki, T., Petersen, G. M., Vogelstein, B., Maher, E., Ogawa, M., Maruyama, M., Utsunomiya, J., Baba, S., and Nakamura, Y. Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Human Mutation. 1: 467-473, 1992.
5. Nagase, H., and Nakamura, Y. Mutation of the APC gene. Hum. Mutat., 2: 425-434, 1993.
6. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-31, 1994.
7. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
8. Schutte, M., da Costa, L. T., Hahn, S. A., Moskaluk, C., Hoque, A. T. M. S., Rozenblum, E., Weinstein, C. L., Bittner, M., Meltzer, P. S., Trent, J. M., Yeo, C. J., Hruban, R. H., and Kern, S. E. Identified by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA, 92: 5950-5954, 1995.
9. Hahn. S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at 18q21.1. Science (Washington DC), 271: 350-353, 1996.
10. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC). 244: 207-211, 1989.
11. Teng, D. H-F., Perry, W. L., III. Hogan, J. K., Baumgard, M., Bell, R., Berry, S., Davis, T. D. F., Frye, C., Hattier, T., Hu, R., Jammulapati, S., Janecki, T., Leavitt, A., Mitchell, J. T., Pero, R., Sexton, D., Schroeder, M., Su, P., Swedlund, B., Kyriakis, J. M., Avruch, J., Bartel, P., Wong, A. K. C., Oliphant, A., Thomas, A., Skolnic, M. H., and Tavtigian, S. V. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res., 57: 4177-4182, 1997.
12. Hahn, S. A., Seymour, A. B., Hoque, A. T. M. S., Schutte, M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer. A., Yeo, C. J., Hruban, R. H., and Kern, S. E. Allelotype of pancreatic adenocarcinoma using a xenograft model. Cancer Res., 55: 4670-4675, 1995.
13. Rozenblum, E., Schulte, M., Goggins, M., Hahn, S. A., Lu, J., Panzer, S., Zahurak, M., Goodman, S. N., Hruban, R. H., Yeo, C. J., and Kern, S. E. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res., 57: 1731-1734, 1997.
14. Lin, A., Minden, A., Martinetto, H., Claret, F., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science (Washington DC), 268: 286-290, 1995.
15. Derijard, B., Raingeaud, J., Barret, T., Wu, I., Han, J., Ulevitch, R. J., and Davis, R. J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Washington DC), 267: 682-685, 1995.
16. Derijard, B., Hibi, M., Wu, I., Barret, T., Su, B., Deng, T., Karin, M., and Davis, R. J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76: 1025-1037, 1994.
17. Riggins, G. J., Kinzler, K. W., Vogelstein, B., and Thiagalinbam, S. Frequency of SMAD gene mutations in human cancer. Cancer Res., 57: 2578-2581, 1997.
18. Hahn, S. A., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Schutte, M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H., and Kern, S. E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res., 56: 490-494, 1996.
19. Kong, X. T., Choi, S. H., Inoue, A., Xu, F., Chen, T., Takita, J., Yokota, J., Bessho, F., Yanagisawa, M., Hanada, R., Yamamoto, K., and Hayashi, Y. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Cancer Res., 57: 3772-3778, 1997.
20. Lei, J., Zou, T. T., Shi, Y. Q., Zhou, X., Smolinski, K. N., Yin, J., Souza, R. F., Appel, R., Wang, S., Cymes, K., Chan, O., Abraham, J. M., Harpaz, N., and Meltzer, S. J. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene, 13: 2459-2462, 1996.
21. Takagi, Y., Kohmura, H., Futamura, M., Kida, H., Tanemura, H., Shimokawa, K., and Saji, S. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology, 111: 1369-1372, 1996.
22. Teng, D. H., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., Davis, T., Ha, P. C., Kehrer, R., Jammulapati, S., Chen, Q., Offit, K., Skolnick, M. H., Tavtigian, S. V., Jhanwar, S., Swedlund, B., Wong, A. K., and Kamb, A. Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat. Genet., 13: 241-244, 1996.
23. Miki, Y., Katagiri, T., Kasumi, F., Yoshimoto, T., and Nakamura, Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet., 13: 245-247, 1996.
24. Goggins, M., Schutte, M., Lu, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., and Kern, S. E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res., 56: 5360-5364, 1996.
25. Katagiri, T., Nakamura, Y., and Miki, Y. Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res., 56: 4575-4577, 1996.
26. Kirkpatrick, H., Waber, P., Hoa-Thai, T., Barnes, R., Osborne-Lawrence, S., Truelson, J., Nisen, P., and Bowcock, A. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene, 14: 2189-2193, 1997.
27. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Wilson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC). 268: 1336-1338, 1995.
28. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987. 1995.